Hyperinsulinemia caused by dexamethasone treatment is associated with reduced insulin clearance and lower hepatic activity of insulin-degrading enzyme
- 1 January 2016
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 155, 1-8
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Adequately Adapted Insulin Secretion and Decreased Hepatic Insulin Extraction Cause Elevated Insulin Concentrations in Insulin Resistant Non-Diabetic Adrenal Incidentaloma PatientsPLOS ONE, 2013
- Banting Lecture 2011Diabetes, 2011
- Deletion of Insulin-Degrading Enzyme Elicits Antipodal, Age-Dependent Effects on Glucose and Insulin TolerancePLOS ONE, 2011
- Morphofunctional Alterations in Endocrine Pancreas of Short- and Long-term Dexamethasone-treated RatsHormone and Metabolic Research, 2011
- Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of InsulinPLOS ONE, 2010
- The adaptive compensations in endocrine pancreas from glucocorticoid‐treated rats are reversible after the interruption of treatmentActa Physiologica, 2010
- Glucolipotoxicity of the pancreatic beta cellBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Dexamethasone-induced insulin resistance shows no gender difference in healthy humansDiabetes & Metabolism, 2004
- Beta Cell Adaptation to Dexamethasone-Induced Insulin Resistance in Rats Involves Increased Glucose Responsiveness but not Glucose EffectivenessPancreas, 2001
- Decreased Hepatic Insulin Extraction Precedes Overt Noninsulin Dependent (Type II) Diabetes in Obese MonkeysObesity Research, 1993